Skip to main content
. Author manuscript; available in PMC: 2022 Apr 23.
Published in final edited form as: J Nat Prod. 2021 Feb 23;84(4):1104–1112. doi: 10.1021/acs.jnatprod.0c01163

Table 4.

Pharmacokinetic Parameters of Kratom Alkaloids Following Oral Administration of LKT and OPMS Liquida

MTG
7-HMG
COR
SPC
LKT OPMS liquid LKT OPMS
liquid
LKT OPMS liquid LKT OPMS liquid
Tmax (h) 1.3 ± 0.3 3.1 ± 1.7 0.9 ± 0.2 3.1 ± 1.7 1.0 ± 0.2 3.1 ± 1.7 1.8 ± 0.7 3.2 ± 1.6
Cmax (ng/mL) 63.8 ± 6.2 111.9 ± 15.6 4.3 ± 0.8 4.0 ± 0.6 1.8 ± 0.3 3.1 ± 0.5 21.1 ± 3.3 23.8 ± 1.4
AUC0–24h (h·ng/mL) 479.6 ± 36.4 1306.8 ± 126.1 17.4 ± 4.8 41.0 ± 7.6 8.2 ± 2.3 30.4 ± 9.1 107.4 ± 25.4 222.7 ± 22.2
Cmax/dose (kg·ng/mL/mg) 11.1 ± 1.1 11.7 ± 1.6 14.0 ± 2.3 15.6 ± 2.3 10.4 ± 1.6 10.8 ± 0.6
AUC0–24h/dose (h·kg·ng/mL/mg) 83.7 ± 6.4 136.1 ± 13.1 63.1 ± 18 152.2 ± 45.5 52.9 ± 12.5 101.2 ± 10.1
fold change in AUC0–24h/dose relative to LKT 1.6 2.4 1.9
a

All values represent mean ± SEM (n = 4). Abbreviations: AUC0–24h = area under the plasma concentration–time curve up to 24 h, Cmax = plasma peak concentration, Tmax = time to reach Cmax.